Sorted by Journal

Cancer

ID

Nominee

Article + Nominator(s)

Journal

	2419	Ross RW	Ross RW, Beer TM, Jacobus S, Bubley GJ, Taplin ME, Ryan CW, Huang J, Oh WK. A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone-refractory prostate cancer who are refractory to docetaxel. Cancer 2007;112:521-526. Abstract		Cancer

	Design:		Amedeo Prize Alert